Aramark (ARMK) director reports 699 deferred stock units grant
Aramark (ARMK) reported an insider transaction on 10/10/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aramark (ARMK) reported an insider transaction on 10/10/2025. A director acquired 699 fully vested deferred stock units at $0 by electing to defer the cash retainer into stock units. These units will be settled in shares of common stock on the first day of the seventh month after the director leaves the board.
Following the transaction, the director’s beneficial ownership is 7,966.29 shares, held directly. The balance reflects an adjustment to a previously understated number of shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 699 | $0.00 | $0.00 |
Footnotes (2)
- F1. Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board.
- F2. Balance reflects adjustment to previously understated number of shares.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider activity did Aramark (ARMK) report?
How will the deferred stock units be settled for ARMK?
What was the transaction price for the ARMK deferred units?
What is the director’s beneficial ownership after the ARMK transaction?
What is the insider’s relationship to Aramark?
AI-generated analysis. How Rhea-AI works. Not financial advice.